All Releases
 |
Moody's and S&P Improve Ratings Outlook for Orthofix International
Nov 19, 2009
|
10.5 KB |
|
| |
BOSTON, Nov 19, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that both Standard & Poor's Rating Services and Moody's Investor
Services have improved their outlooks for the Company from negative to
stable.
Moody's Investor Services revised its outlook yesterday, citing
...
|
|
Orthofix International Announces Third Quarter Results And Additional Debt Payment Ahead of Scheduled Maturity
Oct 29, 2009
|
42.2 KB |
|
| |
BOSTON, Oct 29, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced
its results for the third quarter ended September 30, 2009. Total
revenue was $135.1 million, which was an increase of 4% over the third
quarter of 2008. Excluding the unfavorable $3.6 million impact of
for...
|
|
Orthofix International Announces Release Date for Q309 Results
Oct 20, 2009
|
9.3 KB |
|
| |
BOSTON, Oct 20, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it will host a conference call and webcast on Thursday, October 29th,
at 4:30 PM Eastern Time to discuss the Company's results for the third
quarter ended September 30, 2009, which will be released at
...
|
|
Orthofix International to Participate in JMP Securities Healthcare Focus Conference
Sep 30, 2009
|
7.9 KB |
|
| |
BOSTON, Sep 30, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it will participate in the JMP Securities Healthcare Focus
Conference.
Chief Executive Officer Alan Milinazzo is scheduled to give a
presentation on Tuesday, October 6th, at 1:30 PM Eastern Time at the New
...
|
|
Orthofix International to Participate in Morgan Stanley Global Healthcare Unplugged Conference
Sep 9, 2009
|
8.0 KB |
|
| |
BOSTON, Sep 09, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it will participate in the 2009 Morgan Stanley Global Healthcare
Unplugged Conference.
Chief Executive Officer Alan Milinazzo is scheduled to give a
presentation on Monday, September 14th, at 2:45 PM Eastern...
|
|
Orthofix International to Participate in Thomas Weisel Healthcare Conference
Sep 8, 2009
|
7.9 KB |
|
| |
BOSTON, Sep 08, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it will participate in the Thomas Weisel Partners Healthcare
Conference in Boston.
Chief Executive Officer Alan Milinazzo is scheduled to give a
presentation on Friday, September 11th, at 8:00 AM Eastern Tim...
|
|
Orthofix International Names Accomplished Medical Device Industry Executive to Board of Directors
Aug 19, 2009
|
8.2 KB |
|
| |
BOSTON, Aug 19, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) announced today that Michael
R. Mainelli has joined the Company's Board of Directors.
Mr. Mainelli is an accomplished public company executive with 16 years
of experience in the medical device industry. He spent eight years with
Stryker Corpo...
|
|
Orthofix International Appoints Former Stryker Executive as President of Spinal Implants Division
Aug 17, 2009
|
8.8 KB |
|
| |
BOSTON, Aug 17, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that Kevin L. Unger has been appointed as President of the Company's
spinal implants division. Mr. Unger will report directly to Brad Mason,
who was previously named Group President of North America and has been
...
|
|
Orthofix International to Participate in Canaccord Adams 29th Annual Global Growth Conference
Aug 10, 2009
|
8.0 KB |
|
| |
BOSTON, Aug 10, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it will participate in Canaccord Adams' 29th Annual
Global Growth Conference in Boston.
Chief Executive Officer Alan Milinazzo is scheduled to give a
presentation on Thursday, August 13th, at 1:30 PM Eastern...
|
|
Orthofix International Announces Record Revenue in 2nd Quarter 2009
Jul 30, 2009
|
38.4 KB |
|
| |
BOSTON, Jul 30, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced
its results for the second quarter ended June 30, 2009. Total quarterly
revenue was a record $137.5 million, which was an increase of 6% over
the second quarter of 2008. Excluding the unfavorable $5.5 million
...
|
|
Orthofix International Announces Development & Marketing Agreement with Stout Medical Group
Jul 22, 2009
|
9.9 KB |
|
| |
BOSTON, Jul 22, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that the Company has signed a License and Product Development Agreement
with Stout Medical Group, LP for the development and marketing of a new
expandable vertebral body replacement (VBR) and corpectomy device.
"...
|
|
Orthofix International Announces Release Date for Q209 Results
Jul 16, 2009
|
9.2 KB |
|
| |
BOSTON, Jul 16, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
announced that it will host a conference call and webcast on Thursday,
July 30th, at 4:30 PM Eastern Time to discuss the Company's
results for the second quarter ended June 30, 2009, which will be
released...
|
|
Orthofix International to Participate in Jefferies 3rd Annual Healthcare Conference
Jun 15, 2009
|
7.9 KB |
|
| |
BOSTON, Jun 15, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it will participate in Jefferies' 3rd Annual Healthcare Conference
in New York City.
Executive Vice President and Chief Financial Officer Bob Vaters is
scheduled to give a presentation on Wednesday, June 17t...
|
|
Orthofix International Announces 1st Quarter 2009 Results And Additional Debt Payment Ahead of Scheduled Maturity
May 6, 2009
|
35.6 KB |
|
| |
BOSTON, May 06, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced
its results for the first quarter ended March 31, 2009. As the Company
previously announced, total revenue was $129.0 million, which was an
increase of 1% over the first quarter of 2008. Excluding the unfavorable
...
|
|
Orthofix International Announces Limited Market Release of Trinity(R) Evolution(TM) and Completion of First Surgical Procedure Using New Stem Cell-Based Allograft
May 5, 2009
|
10.1 KB |
|
| |
BOSTON, May 05, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that the Company has begun the limited market release of Trinity(R)
Evolution(TM) in collaboration with the Musculoskeletal
Transplant Foundation (MTF). Trinity Evolution is a stem cell-based bone
growth m...
|
|
Orthofix International Announces Retirement of Peter Hewett From Board of Directors
May 1, 2009
|
9.1 KB |
|
| |
BOSTON, May 01, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that Peter Hewett will be retiring from the Company's Board of Directors
and will not seek reelection at the upcoming Annual General Meeting. Mr.
Hewett has been a Director of Orthofix since March of 1992. He was ...
|
|
Orthofix International Announces Expanded Three-Year Supply Contract with Novation
Apr 21, 2009
|
8.4 KB |
|
| |
BOSTON, Apr 21, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
that its sport medicine division, BREG Inc., has entered into an
expanded three-year supply agreement with Novation, the health care
industry's leading contracting services company covering more than 2,500
...
|
|
Orthofix International AnnouncesQ109 Preliminary Results andRelease Date for Final Results
Apr 17, 2009
|
10.3 KB |
|
| |
BOSTON, Apr 17, 2009 (BUSINESS WIRE) -- Orthofix International N.V., (NASDAQ:OFIX) (the Company) today announced
preliminary results for the first quarter of 2009, indicating that the
Company expects to report total revenue of approximately $129.0 million
and earnings in the range of $0.14 to $0.16 per diluted share. The
...
|
|
Orthofix International Reports Unsealing of Previously Filed False Claims Act Complaint Against Manufacturers of Bone Growth Stimulators
Apr 15, 2009
|
8.3 KB |
|
| |
BOSTON, Apr 15, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) today announced
that a federal False Claims Act, or qui tam, complaint filed on March
23, 2005 against the primary manufacturers of bone growth stimulators in
the U.S., including the Company, has been unsealed by the United State...
|
|
Orthofix International Announces New Agreement To Expand Distribution of Spine Implants in the U.K.
Apr 15, 2009
|
10.1 KB |
|
| |
BOSTON, Apr 15, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
it has signed an agreement with the MBA Group (MBA) to expand the
distribution of the Company's spine implant and biologic devices in the
United Kingdom.
As the largest private independent distributor of orthoped...
|
|
|
Shareholder Briefcase
Request Information
Email Alerts
Download Library
RSS News Feeds
